Akt and Cks1 are related with lymph node metastasis in gastric adenocarcinoma

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 932-937

  Lee, Seung Woo ^a   Kang, Sang Bum ^a   Lee, Dong Soo ^a   Lee, Jung Uee ^a  

^a Daejeon St Mary's Hospital   (South Korea)

Author keywords

Adenocarcinoma; Akt; Cks1; P27; Stomach

Indexed keywords

PROTEIN; PROTEIN CKS1; PROTEIN KINASE B; PROTEIN P27; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR INVASION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CDC2-CDC28 KINASES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84879574380     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge121214     Document Type: Article

References (40)

1. Jung KW, Park S, Kong HJ, et al.: Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011; 43:1-11.
2. Brenner H, Rothenbacher D, Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 2009; 472:467-477.
3. Endoh Y, Sakata K, Tamura G, et al.: Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000; 191:257-263. (Pubitemid 30441248)
4. Saegusa M, Takano Y, Kamata Y, Okayasu J: Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas. J Cancer Res Clin Oncol 1996; 122:427-432. (Pubitemid 26226269)
5. Franke TF, Kaplan DR, Cantley LC: PI3K: downstream AK-Tion blocks apoptosis. Cell 1997; 88:435-437. (Pubitemid 27154408)
6. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96:4240-4245. (Pubitemid 29190320)
7. Chang F, Lee JT, Navolanic PM, et al.: Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17:590-603. (Pubitemid 36395654)
8. Fresno Vara JA, Casado E, de Castro J, et al.: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004; 30:193-204.
9. Wang R, Brattain MG: AKT can be activated in the nucleus. Cell Signal 2006; 18:1722-1731. (Pubitemid 44216128)
10. Ermoian RP, Furniss CS, Lamborn KR, et al.: Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 2002; 8:1100-1106. (Pubitemid 34517646)
11. Yamamoto S, Tomita Y, Hoshida Y, et al.: Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004; 10:2846-2850. (Pubitemid 38509164)
12. Liang J, Zubovitz J, Petrocelli T, et al.: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat Med 2002; 8:1153-1160. (Pubitemid 35175971)
13. Shin I, Yakes FM, Rojo F, et al.: PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 2002; 8:1145-1152. (Pubitemid 35175970)
14. Viglietto G, Motti ML, Bruni P, et al.: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002; 8:1136-1144. (Pubitemid 35175969)
15. Greene FL: AJCC cancer staging handbook: TNM classification of malignant tumors. 6th ed. New York; London: Springer 2002.
16. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
17. Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 1999; 13:2905-2927.
18. Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501. (Pubitemid 37328931)
19. Chen WS, Xu PZ, Gottlob K, et al.: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001; 15:2203-2208. (Pubitemid 32843832)
20. Cho H, Thorvaldsen JL, Chu Q, et al.: Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001; 276:38349-38352.
21. Cho H, Mu J, Kim JK, et al.: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292:1728-1731. (Pubitemid 32506248)
22. Garofalo RS, Orena SJ, Rafidi K, et al.: Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 2003; 112:197-208. (Pubitemid 38056356)
23. Easton RM, Cho H, Roovers K, et al.: Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005; 25:1869-1878. (Pubitemid 40280150)
24. Tschopp O, Yang ZZ, Brodbeck D, et al.: Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005; 132:2943-2954. (Pubitemid 41086730)
25. Grille SJ, Bellacosa A, Upson J, et al.: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63:2172-2178. (Pubitemid 36538623)
26. Horiguchi A, Oya M, Uchida A, et al.: Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. J Urol 2003; 169:710-713. (Pubitemid 36133028)
27. Schmitz KJ, Otterbach F, Callies R, et al.: Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod Pathol 2004; 17:15-21. (Pubitemid 41656447)
28. Han Z, Wu K, Shen H, et al.: Akt1/protein kinase B alpha is involved in gastric cancer progression and cell proliferation. Dig Dis Sci 2008; 53:1801-1810. (Pubitemid 351748978)
29. Lee BL, Kim WH, Jung J, et al.: A hypoxia-independent upregulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 2008; 29:44-51. (Pubitemid 351201740)
30. Murakami D, Tsujitani S, Osaki T, et al.: Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy. Gastric Cancer 2007; 10:45-51. (Pubitemid 46356263)
31. Vindigni C, Miracco C, Spina D, et al.: Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type. Int J Cancer 1997; 74:637-641. (Pubitemid 28037508)
32. Yu HG, Ai YW, Yu LL, et al.: Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer 2008; 122:433-443.
33. Cinti C, Vindigni C, Zamparelli A, et al.: Activated Akt as an indicator of prognosis in gastric cancer. Virchows Arch 2008; 453:449-455.
34. Almhanna K, Strosberg J, Malafa M: Targeting AKT Protein Kinase in Gastric Cancer. Anticancer Res 2011; 31:4387-4392.
35. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74. (Pubitemid 24228301)
36. Ganoth D, Bornstein G, Ko TK, et al.: The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3:321-324. (Pubitemid 32201330)
37. Spruck C, Strohmaier H, Watson M, et al.: A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 2001; 7:639-650. (Pubitemid 32706355)
38. Masuda TA, Inoue H, Nishida K, et al.: Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res 2003; 9:5693-5698. (Pubitemid 37499492)
39. Shapira M, Ben-Izhak O, Linn S, et al.: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005; 103:1336-1346. (Pubitemid 40410727)
40. Slotky M, Shapira M, Ben-Izhak O, et al.: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res 2005; 7:R737-744.